跳至主要内容
临床试验/JPRN-UMIN000032766
JPRN-UMIN000032766已完成未知

The persistence of tadalafil monotherapy and the reasons for withdrawal from treatment of treatment-naive patients with benign prostatic hyperplasia in the real-world clinical setting - Persistence and reasons for withdrawal of tadalafil

Hokkaido Prefectural Esashi Hospital0 个研究点目标入组 113 人开始时间: 2018年6月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
113

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
50years-old 至 ot applicable(—)
性别
Male

入选标准

  • 未提供

排除标准

  • urinary tract infection, acute urinary retention, prostate cancer, neurogenic bladder, the use of an alpha-1 adrenoceptor antagonist or anti-androgen, and a history of prostatic surgery

研究者

相似试验

招募中
2 期
Effect of continuous use of Tadalafil on men’s sexual function after surgeryErectile dysfunction.Male erectile dysfunction
IRCT20201111049350N1Tabriz University of Medical Sciences80
进行中(未招募)
1 期
A study in children with Pulmonary Arterial Hypertension to assess the safety of Tadalafil as the dose increases, as well as how the drug works in the bodyPulmonary Arterial Hypertension
EUCTR2011-001873-24-ESEli Lilly and Company19
进行中(未招募)
1 期
A study in children with Pulmonary Arterial Hypertension to assess the safety of Tadalafil as the dose increases, as well as how the drug works in the bodyPulmonary Arterial HypertensionMedDRA version: 18.1Level: PTClassification code 10064911Term: Pulmonary arterial hypertensionSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders
EUCTR2011-001873-24-PLEli Lilly and Company24
进行中(未招募)
1 期
A study in children with Pulmonary Arterial Hypertension to assess the safety of Tadalafil as the dose increases, as well as how the drug works in the bodyMedDRA version: 17.1Level: PTClassification code 10064911Term: Pulmonary arterial hypertensionSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersPulmonary Arterial Hypertension
EUCTR2011-001873-24-GBEli Lilly and Company19
招募中
不适用
Comparison of tadalafil monotherapy and its combination with mirabegron for efficacy in the treatment of storage symptoms with benign prostatic hyperplasiaBenign prostatic hyperplasia
JPRN-UMIN000030560Division of Urology, Department of Surgery, Tottori University Faculty of Medicine120
The persistence of tadalafil monotherapy and the... | 临床试验